Your browser doesn't support javascript.
loading
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
Gandhi, Rajesh T; McMahon, Deborah K; Bosch, Ronald J; Lalama, Christina M; Cyktor, Joshua C; Macatangay, Bernard J; Rinaldo, Charles R; Riddler, Sharon A; Hogg, Evelyn; Godfrey, Catherine; Collier, Ann C; Eron, Joseph J; Mellors, John W.
Afiliação
  • Gandhi RT; Department of Infectious Diseases, Massachusetts General Hospital and Ragon Institute, Boston, Massachusetts, United States of America.
  • McMahon DK; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Bosch RJ; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Lalama CM; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Cyktor JC; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Macatangay BJ; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Rinaldo CR; Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Riddler SA; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Hogg E; Social & Scientific Systems, Inc., Silver Spring, Maryland, United States of America.
  • Godfrey C; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
  • Collier AC; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Eron JJ; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Mellors JW; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
PLoS Pathog ; 13(4): e1006285, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28426825
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Antirretrovirais / Inflamação Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Antirretrovirais / Inflamação Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article